832-497-2220 info@mybiogate.com

Forbes released its annual Midas List of the best dealmakers in venture capital and the Chinese were outstanding in the 2019 rankings.

Selected Deals in 2019

  • Apic Bio completed a $40 million Series A financing led by Morningside Venture
  • Cullgen of San Diego Raises $16 Million in Series A from China Investors
  • Genenta Science of Milan Raises $14.6 Million in Funding Led by China Investor

However, the questions are: Which VCs are pouring money into the healthcare sector? Which ones provide more than just a checkbook and bring true value in the form of strategy? Which China-based firms have insatiable appetite for oversea investment?
Here we track down the most important China VCs you should know.

Top China VCs in Healthcare Sector

There are companies in China that haven’t even started clinical trials, and they have received term sheets for $400 million.” said Nisa Leung, managing partner at Qiming Venture Partners.

Excitingly, Amy Tang, the venture partner at Qiming Venture will join China Focus@San Francisco company presentation track, to scout for potential investment opportunities.

Confirmed Top VCs
  • Amy Tang: Venture Partner, Qiming Venture
  • Jimmy Zhang: Venture Partner, Lilly Asia Ventures
  • John Zhu: Partner, 6 Dimensions Capital
  • Lily Shen: Managing Director, Morningside Group
  • Nanan Chang, VP, Kaitai Capital

Of course, there are common obstacles tied with fundraising in China, and it is critical for healthcare executives to know before diving in. Therefore, we invited Zhenhua Wu, CEO at Exegenesis Bio who recently closed $10 Million Initial Funding from China Investors, to share his success story and take questions from the presenting companies. 
Secure a presenting slot and get the fundraising rolling!

Apply Now

In order to help you better understand China Focus conference and company presentation opportunity, we will hold “Everything you need to know about China Focus” live webinar. Register for FREE today!

Date & Time:  Dec 18, 2019 8:00 PM in Central Time (US and Canada)
Duration: 1 hour

Save Your Slot



During the 2020 JP Morgan Healthcare Conference, GenScript Biotech Global Forum will be taking place on, January 14, at Grand Hyatt San Francisco, U.S.
Under the theme of “Cell & Gene Therapy and Booming China Market”, the conference aims to build a bridge between the cell & gene therapy industry and capital community, accelerating the mutual understanding and creating collaboration opportunities worldwide.
Registration fee: $50.
Please click here for more information.